The Global Tribune

Acute Heart failure Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved

 Breaking News
  • No posts were found

Acute Heart failure Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved

February 17
19:38 2021
Acute Heart failure Competitive Analysis Report 2020: Emerging Therapies and Key Pharma Players Involved

DelveInsight Business Research LLP
“Acute Heart failure (AHF) Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Heart failure (AHF) market. A detailed picture of the Acute Heart failure (AHF) pipeline landscape is provided, which includes the disease overview and Acute Heart failure (AHF) treatment guidelines.

DelveInsight launched a new report on Acute Heart failure Pipeline Insight, 2020.

Acute Heart failure (AHF) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Heart failure (AHF) market. A detailed picture of the Acute Heart failure (AHF) pipeline landscape is provided, which includes the disease overview and Acute Heart failure (AHF) treatment guidelines.

Heart Failure (HF), also known as congestive HF, is bifurcated as left-side HF (when the heart is unable to pump enough oxygen in the blood to the body) and right-side HF (when the heart is unable to fill itself with enough blood).
 
Acute heart failure (AHF) is broadly defined as a rapid onset of new or worsening signs and symptoms of HF. It is often a potentially life-threatening condition requiring hospitalization, and emergency treatment aim to manage fluid overload and hemodynamic compromise. This umbrella term includes patients presenting for the first time with typical symptoms and signs of heart failure (de novo AHF) and those with worsening of their pre-existing cardiomyopathy (acute decompensated heart failure). 
 
 
Key Pharma Players involved:

1. Boehringer Ingelheim/Eli Lilly and Company

2. Windtree Therapeutics

3. Arena Pharmaceuticals

Click here and get access to free sample pages of our report.

Table of Contents:

1. Report Introduction

2. Acute Heart failure (AHF) 

4. Acute Heart failure (AHF) – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Acute Heart failure (AHF) Late Stage Products (Phase-III)

7. Acute Heart failure (AHF) Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Acute Heart failure (AHF) Discontinued Products

13. Acute Heart failure (AHF) Product Profiles

14. Acute Heart failure (AHF) Key Companies

15. Acute Heart failure (AHF) Key Products

16. Dormant and Discontinued Products

17. Acute Heart failure (AHF) Unmet Needs

18. Acute Heart failure (AHF) Future Perspectives

19. Acute Heart failure (AHF) Analyst Review  

20. Appendix

21. Report Methodology

Download our report: https://www.delveinsight.com/report-store/acute-heart-failure-ahf-pipeline-insight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/